Suppr超能文献

局部手术治疗对 T1 期年轻乳腺癌女性生存的影响:基于人群队列的长期结果。

Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.

机构信息

Division of Breast and Thyroid Surgical Oncology, Department of Surgery, The Catholic University of Korea St. Vincent's Hospital, 93 Joongboo-Daero Paldal-gu, Suwon, 442-723, Kyounggi-do, South Korea.

出版信息

Breast Cancer Res Treat. 2013 Apr;138(2):475-84. doi: 10.1007/s10549-013-2456-7. Epub 2013 Mar 3.

Abstract

The aim of this study was to analyze the effect of the type of local surgical treatment on survival in young women aged less than 40 years with T1 breast cancer. We analyzed data from 3,512 patients aged ≤40 years old who were diagnosed with T1 breast cancer from the Korean Breast Cancer Registry database between January 1988 and December 2006 and underwent either breast-conserving therapy (BCT) or mastectomy. The overall survival (OS) and breast-cancer-specific survival (BCSS) were compared between BCT and mastectomy. Of the 3,512 patients analyzed, 1,951 (55.6 %) underwent BCT, and 1,561 (44.4 %) underwent mastectomy. The median follow-up period was 111.0 (79.0-131.5) months. Overall, the 10-year OS rates for BCT and mastectomy were 95 and 92.1 %, respectively (p = 00004), and the 10-year BCSS rates for BCT and mastectomy patients were 96.9 and 94.9 %, respectively (p = 0.12). In node-negative patients, no significant difference was observed in either the OS (adjusted hazard ratio [HR] 1.072; 95 % CI, 0.750-1.5332, p = 0.704) or BCSS (adjusted HR 0.988; 95 % CI, 0.620-1.574, p = 0.960) rate between the BCT and mastectomy groups. In node-positive patients, no significant difference was observed in the OS (adjusted HR 1.634; 95 % CI, 0.982-2.272, p = 0.59) and BCSS (adjusted HR 1.410; 95 % CI, 0.755-2.633, p = 0.281) rates between the BCT and mastectomy groups. In this large, population-based analysis of young women with T1 breast cancer, the OS and BCSS were not different between BCT and mastectomy.

摘要

本研究旨在分析局部手术治疗类型对≤40 岁 T1 期乳腺癌年轻女性生存的影响。我们分析了 1988 年 1 月至 2006 年 12 月期间韩国乳腺癌登记数据库中诊断为 T1 期乳腺癌且≤40 岁的 3512 例患者的数据,这些患者分别接受了保乳治疗(BCT)或乳房切除术。比较了 BCT 和乳房切除术之间的总生存(OS)和乳腺癌特异性生存(BCSS)。在分析的 3512 例患者中,1951 例(55.6%)接受了 BCT,1561 例(44.4%)接受了乳房切除术。中位随访时间为 111.0(79.0-131.5)个月。总体而言,BCT 和乳房切除术的 10 年 OS 率分别为 95%和 92.1%(p=0.00004),BCT 和乳房切除术患者的 10 年 BCSS 率分别为 96.9%和 94.9%(p=0.12)。在淋巴结阴性患者中,BCT 和乳房切除术组之间的 OS(调整后的风险比[HR]1.072;95%CI,0.750-1.5332,p=0.704)或 BCSS(调整后的 HR 0.988;95%CI,0.620-1.574,p=0.960)率无显著差异。在淋巴结阳性患者中,BCT 和乳房切除术组之间的 OS(调整后的 HR 1.634;95%CI,0.982-2.272,p=0.59)和 BCSS(调整后的 HR 1.410;95%CI,0.755-2.633,p=0.281)率无显著差异。在这项对 T1 期乳腺癌年轻女性的大型基于人群的分析中,BCT 和乳房切除术之间的 OS 和 BCSS 无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验